Virtu Financial’s Viking Therapeutics VKTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
Sell
-14,350
Closed -$347K 2065
2025
Q1
$347K Sell
14,350
-28,263
-66% -$683K 0.02% 614
2024
Q4
$1.72M Buy
+42,613
New +$1.72M 0.09% 184
2024
Q3
Sell
-27,569
Closed -$1.46M 1923
2024
Q2
$1.46M Buy
+27,569
New +$1.46M 0.1% 201
2024
Q1
Sell
-29,394
Closed -$547K 2142
2023
Q4
$547K Buy
29,394
+3,866
+15% +$71.9K 0.04% 381
2023
Q3
$283K Sell
25,528
-52,701
-67% -$584K 0.03% 530
2023
Q2
$1.27M Buy
+78,229
New +$1.27M 0.1% 164
2022
Q4
Sell
-16,941
Closed -$46K 2171
2022
Q3
$46K Buy
+16,941
New +$46K ﹤0.01% 1223
2022
Q1
Sell
-12,633
Closed -$58K 2069
2021
Q4
$58K Buy
+12,633
New +$58K 0.01% 1306
2021
Q3
Sell
-22,929
Closed -$137K 1998
2021
Q2
$137K Buy
+22,929
New +$137K 0.01% 1119
2021
Q1
Sell
-37,152
Closed -$209K 2051
2020
Q4
$209K Buy
+37,152
New +$209K 0.02% 833
2020
Q3
Sell
-12,761
Closed -$92K 1549
2020
Q2
$92K Buy
+12,761
New +$92K 0.01% 904
2019
Q4
Sell
-12,071
Closed -$83K 1889
2019
Q3
$83K Sell
12,071
-8,165
-40% -$56.1K 0.01% 1120
2019
Q2
$168K Sell
20,236
-143,546
-88% -$1.19M 0.01% 1040
2019
Q1
$1.63M Buy
163,782
+146,438
+844% +$1.46M 0.09% 174
2018
Q4
$133K Sell
17,344
-9,729
-36% -$74.6K 0.01% 1056
2018
Q3
$472K Sell
27,073
-29,460
-52% -$514K 0.03% 617
2018
Q2
$536K Buy
+56,533
New +$536K 0.03% 749
2017
Q4
Sell
-36,588
Closed -$70K 3055
2017
Q3
$70K Buy
+36,588
New +$70K ﹤0.01% 2162